FR2554109A1 - Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation en therapeutique comme medicaments - Google Patents

Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation en therapeutique comme medicaments Download PDF

Info

Publication number
FR2554109A1
FR2554109A1 FR8416236A FR8416236A FR2554109A1 FR 2554109 A1 FR2554109 A1 FR 2554109A1 FR 8416236 A FR8416236 A FR 8416236A FR 8416236 A FR8416236 A FR 8416236A FR 2554109 A1 FR2554109 A1 FR 2554109A1
Authority
FR
France
Prior art keywords
group
residue
carbon atoms
separated
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
FR8416236A
Other languages
English (en)
French (fr)
Inventor
Arnold Vogel
Gerhard Bormann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2554109A1 publication Critical patent/FR2554109A1/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
FR8416236A 1983-11-01 1984-10-22 Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation en therapeutique comme medicaments Pending FR2554109A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CH589383 1983-11-01
CH589583 1983-11-01
CH589183 1983-11-01
CH357884 1984-07-24
CH358084 1984-07-24

Publications (1)

Publication Number Publication Date
FR2554109A1 true FR2554109A1 (fr) 1985-05-03

Family

ID=27509144

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8416236A Pending FR2554109A1 (fr) 1983-11-01 1984-10-22 Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation en therapeutique comme medicaments

Country Status (12)

Country Link
AU (1) AU3486884A (it)
BE (1) BE900874A (it)
DE (1) DE3438884A1 (it)
DK (1) DK517484A (it)
FR (1) FR2554109A1 (it)
GB (1) GB2148895A (it)
IL (1) IL73363A0 (it)
IT (1) IT1199214B (it)
LU (1) LU85621A1 (it)
NL (1) NL8403302A (it)
SE (1) SE8405450L (it)
WO (1) WO1985001940A1 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3420784A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 3-nitro-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000150A1 (en) * 1977-06-20 1979-01-10 Sandoz Ag Dihydropyridine derivatives, process for their production and pharmaceutical compositions containing them.
EP0002208A1 (de) * 1977-11-26 1979-06-13 Bayer Ag Nitrosubstituierte 1,4-Dihydropyridine, diese enthaltende Arzneimittel sowie deren Herstellung
DE2949464A1 (de) * 1978-12-18 1980-06-26 Sandoz Ag Benzoxadiazole und benzothiadiazole, ihre herstellung und verwendung
EP0071819B1 (de) * 1981-07-30 1987-04-22 Bayer Ag Dihydropyridine mit positiv inotroper Wirkung, neue Verbindungen, ihre Verwendung in Arzneimitteln und Verfahren zu ihrer Herstellung

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000150A1 (en) * 1977-06-20 1979-01-10 Sandoz Ag Dihydropyridine derivatives, process for their production and pharmaceutical compositions containing them.
EP0002208A1 (de) * 1977-11-26 1979-06-13 Bayer Ag Nitrosubstituierte 1,4-Dihydropyridine, diese enthaltende Arzneimittel sowie deren Herstellung
DE2949464A1 (de) * 1978-12-18 1980-06-26 Sandoz Ag Benzoxadiazole und benzothiadiazole, ihre herstellung und verwendung
EP0071819B1 (de) * 1981-07-30 1987-04-22 Bayer Ag Dihydropyridine mit positiv inotroper Wirkung, neue Verbindungen, ihre Verwendung in Arzneimitteln und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
SE8405450D0 (sv) 1984-10-31
WO1985001940A1 (en) 1985-05-09
BE900874A (fr) 1985-04-23
IL73363A0 (en) 1985-01-31
DK517484D0 (da) 1984-10-30
NL8403302A (nl) 1985-06-03
DK517484A (da) 1985-05-02
IT8449079A0 (it) 1984-10-29
AU3486884A (en) 1985-05-09
GB2148895A (en) 1985-06-05
LU85621A1 (fr) 1985-07-17
DE3438884A1 (de) 1985-05-09
SE8405450L (sv) 1985-06-10
GB8427443D0 (en) 1984-12-05
IT1199214B (it) 1988-12-30
IT8449079A1 (it) 1986-04-29

Similar Documents

Publication Publication Date Title
EP0370901B1 (fr) Nouveaux dérivés du chromanne actifs sur le système nerveux central, leur procédé de préparation et les compositions pharmaceutiques en contenant
US5856346A (en) Short-acting dihydropyridines
FR2679903A1 (fr) Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant.
JPS626703B2 (it)
FR2567885A1 (fr) Derives 3-aminopropoxyaryliques, leur preparation, leur application comme medicaments et compositions pharmaceutiques les contenant
EP0217700B1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique
FR2501686A1 (fr) Nouveaux derives de 3,4-dihydro-5h-2,3-benzodiazepine, procede pour les preparer et medicaments les contenant
FR2498188A1 (fr) Nouveaux derives de l'indole, leur preparation et leur application comme medicaments
EP0373998A1 (fr) Ethers d'oxime de propénone, procédé pour leur préparation et compositions pharmaceutiques les contenant
EP0538080A1 (fr) Dérivés de l'aminométhyl-4 pipéridine, leur préparation et leur application en thérapeutique
FR2495153A1 (fr) Nouvelles dibenzazepines, leur preparation et leur application comme medicaments
FR2566404A1 (fr) Nouveaux derives de la 1,4-dihydropyridine, leurs sels, procede pour les preparer, et compositions pharmaceutiques les contenant
JPS6360755B2 (it)
FR2480284A1 (fr) Amines antihypertensives, leur procede de preparation et compositions antihypertensives en contenant.
FR2549058A1 (fr) Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments
EP0004494A1 (fr) Nouveaux dérivés de 1,3-dihydro 3-(1-(2-(2,3-dihydro 1,4-benzo-dioxin-2-yl)2-hydroxy éthyl)pipéridin-4-yl)2H-indol 2-one, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant
FR2528431A1 (fr) Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments
EP0511031B1 (fr) Dérivés d'aryl-3 oxazolidinone, leur procédé de préparation et leur application en thérapeutique
EP0322263B1 (fr) Carbamates tricycliques, leur procédé de préparation et leur application en thérapeutique
FR2554109A1 (fr) Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation en therapeutique comme medicaments
EP0240398A1 (fr) Dérivés dissymétriques de l'acide 1,4-dihydropyridine-3,5-dicarboxylique, procédés de préparation et utilisation en thérapeutique
FR2615188A1 (fr) Derives d'hydrazine, procede d'obtention et compositions pharmaceutiques les contenant
FR2523128A1 (fr) Nouveaux derives de la 1,4-dihydropyridine, leur preparation et medicaments contenant ces derives
FR2702211A1 (fr) Nouveaux dérivés de la phénoxy-2 éthylamine, leur préparation et leur application en thérapeutique.
EP0100257B1 (fr) Nouveaux dérivés aminoalkyl naphtaléniques, leurs sels d'addition d'acide et le procédé de préparation ainsi que l'application en thérapeutique de ces dérivés et sels